Zacks Investment Management raised its holdings in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 7.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 22,419 shares of the aerospace company’s stock after buying an additional 1,535 shares during the quarter. Zacks Investment Management’s holdings in Leidos were worth $3,654,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in LDOS. Ballentine Partners LLC increased its position in Leidos by 3.5% during the third quarter. Ballentine Partners LLC now owns 1,822 shares of the aerospace company’s stock worth $297,000 after acquiring an additional 62 shares during the period. Key Financial Inc grew its position in Leidos by 6.5% during the second quarter. Key Financial Inc now owns 1,141 shares of the aerospace company’s stock worth $166,000 after buying an additional 70 shares in the last quarter. Asahi Life Asset Management CO. LTD. increased its stake in Leidos by 3.2% during the third quarter. Asahi Life Asset Management CO. LTD. now owns 2,280 shares of the aerospace company’s stock valued at $372,000 after acquiring an additional 70 shares during the period. Somerset Trust Co raised its holdings in Leidos by 3.5% in the 3rd quarter. Somerset Trust Co now owns 2,429 shares of the aerospace company’s stock valued at $396,000 after acquiring an additional 83 shares in the last quarter. Finally, Apella Capital LLC raised its holdings in Leidos by 0.8% in the 3rd quarter. Apella Capital LLC now owns 11,366 shares of the aerospace company’s stock valued at $1,878,000 after acquiring an additional 89 shares in the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.
Leidos Stock Performance
Shares of NYSE:LDOS opened at $163.15 on Monday. The business has a fifty day moving average of $171.81 and a 200-day moving average of $157.46. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.15 and a current ratio of 1.23. Leidos Holdings, Inc. has a twelve month low of $105.52 and a twelve month high of $202.90. The firm has a market cap of $21.77 billion, a PE ratio of 18.58, a price-to-earnings-growth ratio of 1.10 and a beta of 0.64.
Leidos Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.98%. This is a positive change from Leidos’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Monday, December 16th. Leidos’s dividend payout ratio (DPR) is presently 17.31%.
Insider Activity
In other Leidos news, Director Noel B. Geer acquired 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 20th. The shares were acquired at an average cost of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the acquisition, the director now directly owns 2,000 shares of the company’s stock, valued at approximately $322,260. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $184.94, for a total transaction of $193,632.18. Following the completion of the transaction, the director now directly owns 6,408 shares in the company, valued at approximately $1,185,095.52. The trade was a 14.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.96% of the company’s stock.
Analyst Ratings Changes
A number of research firms have recently issued reports on LDOS. TD Cowen boosted their price objective on Leidos from $175.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Barclays boosted their price target on shares of Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Robert W. Baird raised their price objective on shares of Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. JPMorgan Chase & Co. upped their target price on shares of Leidos from $175.00 to $185.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Finally, Citigroup raised their price target on shares of Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $187.36.
Read Our Latest Research Report on LDOS
Leidos Company Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Articles
- Five stocks we like better than Leidos
- Why Are Stock Sectors Important to Successful Investing?
- Guidewire Software Provides Long-Awaited Buying Opportunity
- Low PE Growth Stocks: Unlocking Investment Opportunities
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Fast-Growing Companies That Are Still Undervalued
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.